In a ZCC arbitration, CRA was retained to provide expert reports and testimony regarding the damages suffered by claimant due to the termination of a co-promotion agreement for the commercialization of a pharmaceutical in Germany. As part of the damages assessment, CRA analyzed the German market for the product and the relative contribution to sales performance by each co-promotion partner.
Investment treaty disputes in the life sciences Industry
In its global scale and economic impact, the life sciences industry presents unique considerations for investment treaty arbitrations. The covid-19 pandemic...